• (S)-Mephenytoin: Applied Protocols for CYP2C19 Substrate Ass

  2026-05-29

  (S)-Mephenytoin, as a gold-standard CYP2C19 substrate, enables high-fidelity pharmacokinetic and oxidative drug metabolism studies in advanced in vitro systems. This guide distills experimental workflows, protocol optimizations, and troubleshooting strategies powered by APExBIO’s rigorously validated reagent, contextualized by the latest breakthrough in stem cell-derived intestinal organoid models.

• Causal Roles of CLEC5A and ISG20 in Atherosclerosis Progress

  2026-05-29

  Zhang et al. (2025) integrate Mendelian randomization and eQTL analyses to demonstrate that CLEC5A and ISG20 are causally implicated in atherosclerosis risk. Their study provides molecular evidence for ISG20’s role in macrophage-driven lipid accumulation and inflammation within atherosclerotic lesions, offering new insight into potential therapeutic targets.

• S Tag Peptide: Technical Guidance for Fusion Tag Application

  2026-05-28

  S Tag Peptide (SKU A6007) addresses common bottlenecks in recombinant protein detection, purification, and solubility by providing a small, highly soluble fusion tag compatible with anti-S-Tag antibody detection. It should be used when high solubility and robust affinity purification are required, but is not suitable for applications needing direct enzymatic activity from the tag itself or ethanol-based workflows.

• FXR-KLF11 Axis Suppresses JAK2/STAT3 to Mitigate CI-AKI

  2026-05-28

  This study reveals that activation of the FXR-KLF11 transcriptional axis confers protection against contrast-induced acute kidney injury (CI-AKI) by suppressing JAK2/STAT3-mediated inflammation and apoptosis. The findings highlight a mechanistic advance in CI-AKI pathogenesis and propose FXR agonists as promising prophylactic therapeutics.

• Renin–Angiotensin System Peptides and SARS-CoV-2 Entry via A

  2026-05-27

  A recent study reveals that while Angiotensin II does not modulate SARS-CoV-2 entry via ACE2, its downstream metabolite angiotensin IV can both enhance and inhibit viral entry in a concentration-dependent manner. These findings clarify the distinct roles of renin–angiotensin system peptides in viral infectivity and suggest new considerations for research at the intersection of cardiovascular and infectious disease.

• Hydrocortisone in Translational Research: Mechanisms to Impa

  2026-05-27

  Explore how hydrocortisone’s mechanistic depth as a glucocorticoid hormone empowers translational researchers to bridge inflammation, stress response, and neuroprotection studies. This article uniquely connects cutting-edge findings in cancer stemness and therapy resistance, with actionable protocol guidance and a clear perspective on product selection and workflow integration.

• Omeprazole (A2845): Technical Guidance for Research Use

  2026-05-26

  Omeprazole (SKU A2845) provides a standardized H+,K+-ATPase inhibitor resource for research on gastric acid secretion and antiulcer mechanisms. It is optimized for in vitro and preclinical workflows but is not suitable for diagnostic, clinical, or cross-domain applications. Researchers should follow strict handling and solubility protocols to ensure reproducibility and avoid stability-related errors.

• Annexin V-APC/7-AAD Apoptosis Kit: Precision Apoptosis Detec

  2026-05-26

  The Annexin V-APC/7-AAD Apoptosis Kit enables rapid, dual-parameter apoptosis and necrosis detection with high sensitivity. This apoptosis detection kit leverages phosphatidylserine binding and membrane integrity assessment for robust cell death analysis. The kit is validated for use in cancer, immunology, and cell biology research under rigorous conditions.

• Forskolin: Precision cAMP Modulation for Translational Succe

  2026-05-25

  Explore how Forskolin, a direct adenylate cyclase activator, transforms translational research workflows. This thought-leadership article bridges molecular insight, validated protocols, and cross-domain relevance, offering strategic guidance for stem cell, cardiovascular, and viral infection models.

• Minoxidil Sulphate in Vascular and Hair Growth Research Work

  2026-05-25

  Minoxidil sulphate, the active metabolite of minoxidil, is a high-purity research standard for probing vasodilation and hair follicle mechanisms. This article details experimental protocols, troubleshooting tactics, and recent insights from vascular biology, highlighting how APExBIO’s validated compound enhances reproducibility in preclinical workflows.

• Rapamycin-Induced Autophagy Mitigates Lipotoxicity in Salmon

  2026-05-24

  A recent study demonstrates that stimulating autophagy with rapamycin promotes lipid breakdown and reduces lipotoxicity in Atlantic salmon SHK-1 cells. These findings establish a mechanistic link between autophagy activation and lipid homeostasis in fish, offering a new cell-based model for studying metabolic regulation relevant to aquaculture.

• PTBP2 Attenuation Enhances Direct Fibroblast-to-Neuron Conve

  2026-05-23

  The reference study demonstrates that reducing PTBP2 expression markedly improves the efficiency of converting human skin fibroblasts into induced neurons by promoting neuron-specific alternative splicing, particularly in synergy with RBFOX3. These findings provide mechanistic insight into cellular reprogramming strategies for neurodegenerative disease research and highlight alternative splicing modulation as a key axis for direct lineage conversion.

• Adefovir Dipivoxil: Advances in Chronic Hepatitis B Therapy

  2026-05-22

  Hadziyannis and Papatheodoridis's review delineates the clinical and mechanistic advances enabled by adefovir dipivoxil (GS-0393) in treating chronic hepatitis B, highlighting its efficacy in both wild-type and lamivudine-resistant HBV. Their analysis provides foundational evidence for the compound's long-term safety profile and its significance as a nucleotide analog antiviral.

• Pazopanib Hydrochloride: Optimizing Anti-Angiogenic Assays

  2026-05-22

  Pazopanib Hydrochloride (GW786034) empowers cancer research with robust multi-target kinase inhibition, enabling precise dissection of angiogenesis and tumor growth pathways. This guide details advanced experimental workflows, troubleshooting strategies, and actionable insights to unleash the full potential of Pazopanib in preclinical oncology models.

• ISRIB (trans-isomer): Novel Insights for Cognitive Memory an

  2026-05-21

  Discover how ISRIB (trans-isomer), a potent PERK inhibitor, offers unique advantages for dissecting neuroinflammation and memory loss. This article unpacks new experimental evidence and practical assay guidance for cognitive and neurodegenerative disease research.

15008 records 1/1001 page Next 12345 下5页 Last page